To validate the oncogenic function of MCM4 in GBM, we silence MCM4 in U118MG and U251 using siRNAs (siRNA1, siRNA2, and siRNA3) and selected siRNA3 showing better silence effect for further functional experiments (Fig. 7B). This evidence concerns the gene MCM4 and glioblastoma.